The Scotts Miracle-Gro Company (SMG) 10-Q8 May 242024 Q2 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	6 Months Ended
Cover Page - shares	Mar. 30, 2024	May 03, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 30, 2024
Document Transition Report	false
Entity File Number	001-11593
Entity Registrant Name	Scotts Miracle-Gro Co
Entity Central Index Key	0000825542
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	31-1414921
Entity Address, Address Line One	14111 Scottslawn Road,
Entity Address, City or Town	Marysville,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43041
City Area Code	937
Local Phone Number	644-0011
Title of 12(b) Security	Common Shares, $0.01 stated value
Trading Symbol	SMG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		56,799,090

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Income Statement [Abstract]
Net sales	$ 1,525.4	$ 1,531.5	$ 1,935.8	$ 2,058.1
Cost of sales	986.8	1,000.1	1,340.8	1,420.7
Cost of sales—impairment, restructuring and other	74.9	118.7	69.1	129
Gross margin	463.7	412.7	525.9	508.4
Operating expenses:
Selling, general and administrative	178.7	186.3	293.5	314.8
Impairment, restructuring and other	2.1	21.8	(5)	30.2
Other (income) expense, net	10.8	(1.6)	12.6	(1)
Income from operations	272.1	206.2	224.8	164.4
Equity in loss of unconsolidated affiliates	(7)	(7.3)	(29.5)	(18.7)
Interest expense	44.1	48.3	86.8	91
Other non-operating (income) expense, net	1.2	0.8	2.9	(0.8)
Income before income taxes	219.8	149.8	105.6	55.5
Income tax expense	62.3	40.4	28.6	10.8
Net income	$ 157.5	$ 109.4	$ 77	$ 44.7
Earnings Per Share, Basic And Diluted EPS [Abstract]
Basic income (loss) per common share (USD per share)	$ 2.77	$ 1.95	$ 1.36	$ 0.80
Diluted income (loss) per common share (USD per share)	$ 2.74	$ 1.94	$ 1.34	$ 0.80
Weighted-average common shares outstanding during the period (in shares)	56.8	56	56.7	55.8
Weighted-average common shares outstanding during the period plus dilutive potential common shares (in shares)	57.4	56.5	57.3	56.1

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 157.5	$ 109.4	$ 77	$ 44.7
Other comprehensive income (loss):
Net foreign currency translation adjustment	(2.6)	1.1	0.5	8.3
Net unrealized gain (loss) on derivative instruments, net of tax	6.1	(4.8)	(2.1)	(9.6)
Reclassification of net unrealized gain on derivative instruments to net income, net of tax	(0.9)	(8.2)	(2.4)	(11.9)
Net unrealized loss on securities, net of tax	(0.6)	(5.6)	(1.5)	(26)
Pension and other post-retirement benefit adjustments, net of tax	1	(0.3)	(0.4)	(3.2)
Total other comprehensive income (loss)	3	(17.8)	(5.9)	(42.4)
Comprehensive income	$ 160.5	$ 91.6	$ 71.1	$ 2.3

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
OPERATING ACTIVITIES
Net income	$ 77	$ 44.7
Adjustments to reconcile net income to net cash used in operating activities:
Impairment, restructuring and other	5.6	44.4
Share-based compensation expense	44.6	58.3
Depreciation	32.3	33.6
Amortization	7.9	14.1
Deferred taxes	18.8	17.5
Equity in loss of unconsolidated affiliates	29.5	18.7
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	(572.5)	(1,075.6)
Inventories	56.6	205.3
Prepaid and other current assets	(6.7)	(47.5)
Accounts payable	190.8	7.2
Other current liabilities	84.3	123
Other non-current items	(8)	(14.1)
Other, net	0.8	3.5
Net cash used in operating activities	(39)	(566.9)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(54.2)	(51.8)
Proceeds from loans receivable	0	37
Investments in unconsolidated affiliates	(21.4)	0
Other investing, net	4.5	(5.8)
Net cash used in investing activities	(71.1)	(20.6)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	519.3	1,193.2
Repayments under revolving and bank lines of credit and term loans	(314.3)	(583.8)
Dividends paid	(76.2)	(74.9)
Purchase of Common Shares	(4.9)	(6.4)
Cash received from exercise of stock options	1.7	1.2
Other financing, net	17.2	(4)
Net cash provided by financing activities	142.8	525.3
Effect of exchange rate changes on cash	0.5	0.4
Net increase (decrease) in cash and cash equivalents	33.2	(61.8)
Cash and cash equivalents at beginning of period	31.9	86.8
Cash and cash equivalents at end of period	$ 65.1	$ 25

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Current assets:
Cash and cash equivalents	$ 65.1	$ 31.9	$ 25
Accounts receivable, less allowances of $18.2, $22.2 and $15.1, respectively	876.9	304.2	1,035.7
Accounts receivable pledged	0	0	422.2
Inventories	824.3	880.3	1,127.6
Prepaid and other current assets	168.8	181.4	231.9
Total current assets	1,935.1	1,397.8	2,842.4
Investment in unconsolidated affiliates	83.8	91.9	174.2
Property, plant and equipment, net of accumulated depreciation of $791.4, $793.5 and $765.4, respectively	608.2	610.3	588.9
Goodwill	243.9	243.9	254.3
Intangible assets, net	428.9	436.7	565.5
Other assets	624.3	633.1	562.8
Total assets	3,924.2	3,413.7	4,988.1
Current liabilities:
Current portion of debt	57.8	52.3	435.4
Accounts payable	440.4	271.2	415.5
Other current liabilities	562.1	450.2	521.6
Total current liabilities	1,060.3	773.7	1,372.5
Long-term debt	2,760.5	2,557.4	3,138
Other liabilities	354.3	349.9	340.1
Total liabilities	4,175.1	3,681	4,850.6
Commitments and contingencies
Equity (deficit):
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 56.8, 56.0 and 56.5, respectively	353.7	353.1	374.3
Retained earnings	491.8	490.9	990.3
Treasury shares, at cost; 11.4, 12.1 and 11.6 shares, respectively	(977.8)	(998.5)	(1,040)
Accumulated other comprehensive loss	(118.6)	(112.8)	(187.1)
Total equity (deficit)	(250.9)	(267.3)	137.5
Total liabilities and equity (deficit)	$ 3,924.2	$ 3,413.7	$ 4,988.1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 18.2	$ 15.1	$ 22.2
Property, plant and equipment, accumulated depreciation	$ 791.4	$ 765.4	$ 793.5
Common shares stated value (USD per share)	$ 0.01	$ 0.01	$ 0.01
Common shares outstanding (shares)	56.8	56.5	56
Treasury shares, at cost (shares)	11.4	11.6	12.1

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Mar. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia. The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters. Organization and Basis of Presentation The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 30, 2024 and April 1, 2023 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the condensed consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this Quarterly Report on Form 10-Q for the fiscal quarter ended March 30, 2024 (this “Form 10-Q”) should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. The Company’s Condensed Consolidated Balance Sheet at September 30, 2023 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. Accounts Receivable On October 27, 2023, the Company entered into a Master Receivables Purchase Agreement (the “Master Receivables Purchase Agreement”), under which it may sell up to $600.0 of available and eligible outstanding customer accounts receivable generated by sales to four specified customers. The agreement is uncommitted and has an initial term that expires October 25, 2024, unless earlier terminated by the purchaser. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $70.0. Transactions under this agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Condensed Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Condensed Consolidated Statements of Cash Flows. The Company records the discount on sales in the “Other (income) expense, net” line in the Condensed Consolidated Statements of Operations. At March 30, 2024, net receivables of $582.8 were derecognized. During the three and six months ended March 30, 2024, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $758.2 and $955.5, respectively, and the total discount recorded on sales was $10.7 and $12.9, respectively. Supplier Finance Program The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which is deemed to be commercially reasonable. The Company’s outstanding payment obligations under its supplier finance program were $38.5, $31.0 and $18.3 at March 30, 2024, April 1, 2023 and September 30, 2023, respectively, and are recorded within accounts payable in the Condensed Consolidated Balance Sheets. The associated payments were $153.0 and $110.3 for the six months ended March 30, 2024 and April 1, 2023, respectively, and are classified as operating activities in the Condensed Consolidated Statements of Cash Flows. Long-Lived Assets The Company had non-cash investing activities of $10.1 and $15.3 during the six months ended March 30, 2024 and April 1, 2023, respectively, representing unpaid liabilities to acquire property, plant and equipment. Statements of Cash Flows Supplemental cash flow information was as follows: Six Months Ended March 30, April 1, Interest paid $ 83.6 $ 87.4 Income taxes paid (refunded), net — (21.1) Cash flow from operating activities for the six months ended April 1, 2023 was impacted by extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023. The Company also received proceeds of $37.0 during the six months ended April 1, 2023 related to the payoff of seller financing that the Company provided in connection with a fiscal 2017 divestiture, which was classified as an investing activity in the Condensed Consolidated Statements of Cash Flows. RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information , which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

INVESTMENT IN UNCONSOLIDATED AF

INVESTMENT IN UNCONSOLIDATED AFFILIATES	6 Months Ended
INVESTMENT IN UNCONSOLIDATED AFFILIATES	Mar. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS IN UNCONSOLIDATED AFFILIATES	INVESTMENT IN UNCONSOLIDATED AFFILIATES On December 31, 2020, the Company acquired a 50% equity interest in Bonnie Plants, LLC, a joint venture with Alabama Farmers Cooperative, Inc. (“AFC”) focused on planting, growing, developing, distributing, marketing and selling live plants. During the three months ended December 31, 2022, the Company and AFC amended the joint venture agreement to allow AFC to make an additional equity contribution to Bonnie Plants, LLC, and, as a result of this contribution by AFC, the Company’s equity interest in Bonnie Plants, LLC was reduced to 45%. On November 7, 2023, the Company purchased an additional 5% equity interest in Bonnie Plants, LLC from AFC for $21.4, which restored its total equity interest back to 50%. The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings reflected in the Condensed Consolidated Statements of Operations.

IMPAIRMENT, RESTRUCTURING AND O

IMPAIRMENT, RESTRUCTURING AND OTHER	6 Months Ended
IMPAIRMENT, RESTRUCTURING AND OTHER	Mar. 30, 2024
Restructuring and Related Activities [Abstract]
IMPAIRMENT, RESTRUCTURING AND OTHER	IMPAIRMENT, RESTRUCTURING AND OTHER Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Cost of sales—impairment, restructuring and other: Restructuring and other charges, net $ 70.1 $ 99.9 $ 64.0 $ 105.6 Right-of-use asset impairments 0.7 14.1 0.9 15.4 Property, plant and equipment impairments 4.1 4.7 4.2 8.0 Operating expenses—impairment, restructuring and other: Restructuring and other charges (recoveries), net 2.1 21.8 (5.0) 30.2 Total impairment, restructuring and other charges, net $ 77.0 $ 140.5 $ 64.1 $ 159.2 The following table summarizes the activity related to liabilities associated with restructuring activities during the six months ended March 30, 2024: Amounts accrued at September 30, 2023 $ 40.5 Restructuring charges 7.0 Payments (16.3) Amounts accrued at March 30, 2024 $ 31.2 As of March 30, 2024, restructuring accruals include $9.2 that is classified as long-term. During fiscal 2022, the Company began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. These changes and initiatives include reducing the size of the supply chain network, reducing staffing levels and implementing other cost-reduction initiatives. During the second quarter of fiscal 2024, the Company commenced plans to close additional Hawthorne distribution centers. The Company has also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce its on hand inventory to align with the reduced network capacity. During the three and six months ended March 30, 2024, the Company recorded costs of $77.0 and $73.2, respectively, associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. The Company recorded recoveries of $0.5 and incurred costs of $1.4 in its U.S. Consumer segment and incurred costs of $75.4 and $67.8 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended March 30, 2024, respectively. The Company recorded recoveries of $0.1 and $0.9 in its U.S. Consumer segment and incurred costs of $1.9 and $2.3 in its Hawthorne segment, $0.2 and $0.3 in its Other segment and $0.0 and $2.4 at Corporate in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended March 30, 2024, respectively. Costs incurred from the inception of this restructuring initiative through March 30, 2024 were $294.4 for the Hawthorne segment, $46.0 for the U.S. Consumer segment, $1.8 for the Other segment and $25.1 for Corporate. During the three and six months ended April 1, 2023, the Company incurred costs of $136.8 and $151.4, respectively, associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. The Company incurred costs of $0.2 and $1.2 in its U.S. Consumer segment and $118.5 and $127.0 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended April 1, 2023, respectively. The Company incurred costs of $0.1 and $0.3 in its U.S. Consumer segment, $17.1 and $18.2 in its Hawthorne segment and $0.8 and $4.5 at Corporate in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three and six months ended April 1, 2023, respectively. During the three and six months ended March 30, 2024, the Company recorded a gain of $0.0 and $12.1, respectively, in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations associated with a payment received in resolution of a dispute with the former ownership group of a business that was acquired in fiscal 2022. This payment was classified as an operating activity in the Condensed Consolidated Statements of Cash Flows.

INVENTORIES

INVENTORIES	6 Months Ended
INVENTORIES	Mar. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories consisted of the following for each of the periods presented: March 30, April 1, September 30, Finished goods $ 480.9 $ 759.0 $ 506.2 Raw materials 261.3 279.0 272.5 Work-in-process 82.1 89.6 101.6 Total inventories, net $ 824.3 $ 1,127.6 $ 880.3

MARKETING AGREEMENT

MARKETING AGREEMENT	6 Months Ended
MARKETING AGREEMENT	Mar. 30, 2024
Marketing Agreement [Abstract]
MARKETING AGREEMENT	MARKETING AGREEMENT The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto Company, a subsidiary of Bayer AG (“Monsanto”), for the marketing and distribution of certain of Monsanto’s consumer Roundup ® branded products in the United States and certain other specified countries. The annual commission payable under the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”) is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup ® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup ® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0. Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following: • The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto; • Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup ® products in the lawn and garden market (a “Brand Decommissioning Termination”); and • Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party. The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement). The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Condensed Consolidated Statements of Operations are as follows: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Gross commission $ 40.6 $ 48.9 $ 49.5 $ 58.5 Contribution expenses (4.5) (4.5) (9.0) (9.0) Net commission 36.1 44.4 40.5 49.5 Reimbursements associated with Roundup ® marketing agreement 29.0 27.2 48.1 42.4 Total net sales associated with Roundup ® marketing agreement $ 65.1 $ 71.6 $ 88.6 $ 91.9

DEBT

DEBT	6 Months Ended
DEBT	Mar. 30, 2024
Debt Disclosure [Abstract]
DEBT	DEBT The components of debt are as follows: March 30, April 1, September 30, Credit Facilities: Revolving loans $ 314.2 $ 642.5 $ 88.3 Term loans 900.0 950.0 925.0 Senior Notes due 2031 – 4.000% 500.0 500.0 500.0 Senior Notes due 2032 – 4.375% 400.0 400.0 400.0 Senior Notes due 2029 – 4.500% 450.0 450.0 450.0 Senior Notes due 2026 – 5.250% 250.0 250.0 250.0 Receivables facility — 380.0 — Finance lease obligations 17.5 17.9 16.9 Other 5.5 3.1 0.4 Total debt 2,837.2 3,593.5 2,630.6 Less current portions 57.8 435.4 52.3 Less unamortized debt issuance costs 18.9 20.1 20.9 Long-term debt $ 2,760.5 $ 3,138.0 $ 2,557.4 Credit Facilities On April 8, 2022, the Company entered into a sixth amended and restated credit agreement (the “Sixth A&R Credit Agreement”), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0 (the “Sixth A&R Credit Facilities”). The Sixth A&R Credit Agreement will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default. Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement. On June 8, 2022, the Company entered into Amendment No. 1 to the Sixth A&R Credit Agreement (“Amendment No. 1”). Amendment No. 1 increased the maximum permitted leverage ratio for the quarterly leverage covenant until April 1, 2024. Amendment No. 1 also increased the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increased the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when the Company’s quarterly-tested leverage ratio exceeded 4.75. On July 31, 2023, the Company entered into Amendment No. 2 to the Sixth A&R Credit Agreement (“Amendment No. 2”). Amendment No. 2 (i) reduces the revolving loan commitments by $250.0; (ii) increases the maximum permitted leverage ratio for the quarterly leverage covenant until the earlier of (a) October 1, 2025 and (b) subject to certain conditions specified in Amendment No. 2, the termination by the Company of such adjustment (such period, the “Leverage Adjustment Period”); (iii) replaces the interest coverage covenant with a fixed charge coverage covenant; (iv) increases the interest rate applicable to borrowings under the revolving credit facility and the term loan facility by 25 bps for each existing pricing tier and adds a pricing tier applicable to periods when the leverage ratio exceeds 6.00; (v) limits the amount of certain incremental investments, loans and advances to $25.0 during the Leverage Adjustment Period; and (vi) adds the Company’s intellectual property (subject to certain exceptions) as collateral to secure its obligations under the Sixth A&R Credit Agreement. Additionally, Amendment No. 2 limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or other restricted payments in an aggregate amount not to exceed $25.0. Amendment No. 2 also subjects the Company’s ability to make certain investments to pro forma compliance with certain leverage levels specified in Amendment No. 2. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory, equipment and intellectual property (subject to certain exceptions) of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries. At March 30, 2024, the Company had letters of credit outstanding in the aggregate principal amount of $78.0, and had $857.8 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 8.9% and 7.0% for the six months ended March 30, 2024 and April 1, 2023, respectively. The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters, calculated as average total indebtedness, divided by the Company’s earnings before interest, taxes, depreciation and amortization, as adjusted pursuant to the terms of Amendment No. 2 (“Adjusted EBITDA”). Pursuant to Amendment No. 2, the maximum permitted leverage ratio is (i) 7.75 for the second quarter of fiscal 2024, (ii) 6.50 for the third quarter of fiscal 2024, (iii) 6.00 for the fourth quarter of fiscal 2024, (iv) 5.50 for the first quarter of fiscal 2025, (v) 5.25 for the second quarter of fiscal 2025, (vi) 5.00 for the third quarter of fiscal 2025, (vii) 4.75 for the fourth quarter of fiscal 2025 and (viii) 4.50 for the first quarter of fiscal 2026 and thereafter. The Company’s leverage ratio was 6.95 at March 30, 2024. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s fixed charge coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA minus capital expenditures and expense for taxes paid in cash, divided by the sum of interest expense plus restricted payments, as described in Amendment No. 2. The minimum required fixed charge coverage ratio is (i) 0.75 for the second and third quarters of fiscal 2024 and (ii) 1.00 for the fourth quarter of fiscal 2024 and thereafter. The Company’s fixed charge coverage ratio was 0.95 for the twelve months ended March 30, 2024. As of March 30, 2024, the Company was in compliance with all applicable covenants in the agreements governing its debt. Based on the Company’s projections of its financial performance for the twelve-month period subsequent to the date of the filing of this Form 10-Q, the Company expects to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement. However, the Company’s assessment of its ability to meet its future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lenders under the Sixth A&R Credit Agreement to accelerate the maturity of the indebtedness thereunder and would also implicate cross-default provisions under the Senior Notes, as defined below, and cause the Senior Notes to become due and payable at that time. As of March 30, 2024, the Company’s indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,814.2. The Company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default. As part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within the Company’s control. Additionally, the Company has contemplated alternative plans that are subject to market conditions and not in the Company’s control, including, among others, discussions with its lenders to amend the terms of its financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that the Company will be successful in implementing these alternative plans. Senior Notes On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026 (the “5.250% Senior Notes”). The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year. On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029 (the “4.500% Senior Notes”). The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year. On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031 (the “4.000% Senior Notes”). The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year. On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032 (the “4.375% Senior Notes”). The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year. Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes. The Senior Notes contain an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA divided by interest expense excluding costs related to refinancings. The minimum required interest coverage ratio is 2.00. The Company’s interest coverage ratio was 2.48 for the twelve months ended March 30, 2024. Receivables Facility On April 7, 2017, the Company entered into a Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement, as amended (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”), under which the Company could sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers subject to agreeing to repurchase the receivables on a weekly basis. The eligible accounts receivable consisted of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which could be sold under the Receivables Facility was $400.0 and the commitment amount during the seasonal commitment period that began on February 24, 2023 and ended on June 16, 2023 was $160.0. The Receivables Facility expired on August 18, 2023. The sale of receivables under the Receivables Facility was accounted for as short-term debt and the Company continued to carry the receivables on its Condensed Consolidated Balance Sheets, primarily as a result of its requirement to repurchase receivables sold. As of April 1, 2023, there were $380.0 in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $422.2. Interest Rate Swap Agreements The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of March 30, 2024, April 1, 2023 and September 30, 2023 had a maximum total U.S. dollar equivalent notional amount of $700.0, $800.0 and $600.0, respectively. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at March 30, 2024 are shown in the table below: Notional Effective Expiration Fixed 200 (b) 1/20/2022 6/20/2024 0.49 % 200 6/7/2023 6/8/2026 0.80 % 150 6/7/2023 4/7/2027 3.37 % 50 6/7/2023 4/7/2027 3.34 % 100 (b) 11/20/2023 3/22/2027 4.74 % (a) The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement. (b) Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time. Weighted Average Interest Rate

EQUITY

EQUITY	6 Months Ended
EQUITY	Mar. 30, 2024
Equity [Abstract]
EQUITY (DEFICIT)	EQUITY (DEFICIT) The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated: Common Shares Retained Treasury Accumulated Other Total Balance at September 30, 2023 $ 353.1 $ 490.9 $ (998.5) $ (112.8) $ (267.3) Net income (loss) — (80.5) — — (80.5) Other comprehensive income (loss) — — — (8.9) (8.9) Share-based compensation 11.7 — — — 11.7 Dividends declared ($0.66 per share) — (38.0) — — (38.0) Treasury share purchases — — (3.1) — (3.1) Treasury share issuances (15.2) — 15.9 — 0.7 Balance at December 30, 2023 349.6 372.4 (985.7) (121.7) (385.4) Net income (loss) — 157.5 — — 157.5 Other comprehensive income (loss) — — — 3.0 3.0 Share-based compensation 12.4 — — — 12.4 Dividends declared ($0.66 per share) — (38.1) — — (38.1) Treasury share purchases — — (1.7) — (1.7) Treasury share issuances (8.3) — 9.6 — 1.3 Balance at March 30, 2024 $ 353.7 $ 491.8 $ (977.8) $ (118.6) $ (250.9) The sum of the components may not equal due to rounding. Common Shares Retained Treasury Accumulated Other Total Balance at September 30, 2022 $ 364.0 $ 1,020.1 $ (1,091.8) $ (144.6) $ 147.7 Net income (loss) — (64.7) — — (64.7) Other comprehensive income (loss) — — — (24.6) (24.6) Share-based compensation 20.8 — — — 20.8 Dividends declared ($0.66 per share) — (37.5) — — (37.5) Treasury share purchases — — (0.8) — (0.8) Treasury share issuances (17.2) — 35.9 — 18.7 Balance at December 31, 2022 367.6 917.9 (1,056.7) (169.3) 59.5 Net income (loss) — 109.4 — — 109.4 Other comprehensive income (loss) — — — (17.8) (17.8) Share-based compensation 37.2 — — — 37.2 Dividends declared ($0.66 per share) — (37.0) — — (37.0) Treasury share purchases — — (5.6) — (5.6) Treasury share issuances (30.4) — 22.3 — (8.1) Balance at April 1, 2023 $ 374.3 $ 990.3 $ (1,040.0) $ (187.1) $ 137.5 The sum of the components may not equal due to rounding. Accumulated Other Comprehensive Loss Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated: Three Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) Pension and Other Post-Retirement Accumulated Other Balance at December 30, 2023 $ (18.8) $ 10.4 $ (39.5) $ (73.8) $ (121.7) Other comprehensive income (loss) before reclassifications (2.6) 8.2 (0.6) — 5.0 Amounts reclassified from accumulated other comprehensive net income (loss) — (1.2) — 1.6 0.4 Income tax benefit (expense) — (1.8) — (0.6) (2.4) Net current period other comprehensive income (loss) (2.6) 5.2 (0.6) 1.0 3.0 Balance at March 30, 2024 $ (21.4) $ 15.7 $ (40.1) $ (72.9) $ (118.6) Balance at December 31, 2022 $ (21.7) $ 24.8 $ (100.2) $ (72.2) $ (169.3) Other comprehensive income (loss) before reclassifications 1.1 (6.4) (7.3) — (12.6) Amounts reclassified from accumulated other comprehensive net income (loss) — (11.0) — (0.4) (11.4) Income tax benefit (expense) — 4.4 1.7 0.1 6.2 Net current period other comprehensive income (loss) 1.1 (13.0) (5.6) (0.3) (17.8) Balance at April 1, 2023 $ (20.7) $ 11.8 $ (105.7) $ (72.6) $ (187.1) The sum of the components may not equal due to rounding. Six Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) Pension and Other Post-Retirement Accumulated Other Balance at September 30, 2023 $ (21.9) $ 20.1 $ (38.6) $ (72.4) $ (112.8) Other comprehensive income (loss) before reclassifications 0.5 (2.8) (1.5) — (3.8) Amounts reclassified from accumulated other comprehensive net income (loss) — (3.2) — (0.5) (3.7) Income tax benefit (expense) — 1.5 — 0.1 1.6 Net current period other comprehensive income (loss) 0.5 (4.5) (1.5) (0.4) (5.9) Balance at March 30, 2024 $ (21.4) $ 15.7 $ (40.1) $ (72.9) $ (118.6) Balance at September 30, 2022 $ (28.9) $ 33.3 $ (79.7) $ (69.3) $ (144.6) Other comprehensive income (loss) before reclassifications 8.3 (12.9) (34.1) — (38.7) Amounts reclassified from accumulated other comprehensive net income (loss) — (16.0) — (4.3) (20.3) Income tax benefit (expense) — 7.4 8.1 1.1 16.6 Net current period other comprehensive income (loss) 8.3 (21.5) (26.0) (3.2) (42.4) Balance at April 1, 2023 $ (20.7) $ 11.8 $ (105.7) $ (72.6) $ (187.1) The sum of the components may not equal due to rounding. Share-Based Awards Total share-based compensation was as follows for each of the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Share-based compensation $ 28.1 $ 37.2 $ 44.1 $ 57.9 Related tax benefit recognized 4.6 6.1 7.2 10.8 Performance-based awards Performance-based award activity was as follows (based on target award amounts): No. of Wtd. Avg. Grant Date Awards outstanding at September 30, 2023 544,790 $ 76.85 Granted 232,801 74.95 Vested (a) (181,791) 59.88 Forfeited (185,740) 64.66 Awards outstanding at March 30, 2024 410,060 87.03 (a) Vested at a weighted average of 100% of the target performance share units granted. The weighted-average grant-date fair value of performance-based awards granted during the six months ended March 30, 2024 and April 1, 2023 was $74.95 and $65.97 per share, respectively. As of March 30, 2024, there was $8.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based awards that is expected to be recognized over a weighted-average period of 2.6 years. The total fair value of performance-based units vested during the six months ended March 30, 2024 and April 1, 2023 was $10.6 and $17.5, respectively. During the three months ended March 30, 2024, the Company granted performance-based award units with a three year vesting period that include a performance target based on the Company’s total shareholder return relative to a Company selected peer group, among other financial targets. Based on the extent to which the targets are achieved, vested shares may range from 0% to 325% of the award units granted. The grant date fair value of award units based on a total shareholder return performance target was estimated using a Monte Carlo simulation model. Expected market price volatility was based on historical volatility specific to the Common Shares. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant. Details of the assumptions used in the Monte Carlo simulation model are as follows: Expected volatility 36.6 % Risk-free interest rate 4.5 %

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	6 Months Ended
EARNINGS PER COMMON SHARE	Mar. 30, 2024
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The following table presents information necessary to calculate basic and diluted net income per Common Share for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net income $ 157.5 $ 109.4 $ 77.0 $ 44.7 Basic net income per common share Weighted-average common shares outstanding during the period 56.8 56.0 56.7 55.8 Basic net income per common share $ 2.77 $ 1.95 $ 1.36 $ 0.80 Diluted net income per common share Weighted-average common shares outstanding during the period 56.8 56.0 56.7 55.8 Dilutive potential common shares 0.6 0.5 0.6 0.3 Weighted-average common shares outstanding during the period plus dilutive potential common shares 57.4 56.5 57.3 56.1 Diluted net income per common share $ 2.74 $ 1.94 $ 1.34 $ 0.80 Antidilutive stock options outstanding 0.4 0.2 0.6 0.3

INCOME TAXES

INCOME TAXES	6 Months Ended
INCOME TAXES	Mar. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The effective tax rates for the six months ended March 30, 2024 and April 1, 2023 were 27.1% and 19.5%, respectively. The increase in the effective tax rate was driven by favorable discrete items recorded during the six months ended April 1, 2023 which did not reoccur in the six months ended March 30, 2024. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year and includes the impact of discrete items recognized in the quarter. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year-end. Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2020. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to the foreign jurisdictions, a Canadian audit covering fiscal years 2020 through 2021 is in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2018 through 2022. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

CONTINGENCIES

CONTINGENCIES	6 Months Ended
CONTINGENCIES	Mar. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. Regulatory Matters At March 30, 2024, the Company had recorded liabilities of $2.9 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material. Other The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s condensed consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor does it expect the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	6 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	Mar. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes. Exchange Rate Risk Management The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $114.2, $119.1 and $123.1 at March 30, 2024, April 1, 2023 and September 30, 2023, respectively. Contracts outstanding at March 30, 2024 will mature over the next fiscal quarter. Interest Rate Risk Management The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of March 30, 2024, April 1, 2023 and September 30, 2023 had a maximum total U.S. dollar equivalent notional amount of $700.0, $800.0 and $600.0, respectively. Refer to “NOTE 6. DEBT” for the terms of the swap agreements outstanding at March 30, 2024. Included in the AOCL balance at March 30, 2024 was a gain of $9.7 related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions. Commodity Price Risk Management The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Included in the AOCL balance at March 30, 2024 was a gain of $0.2 related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions. The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases: Commodity March 30, April 1, September 30, Urea — 19,500 tons 52,500 tons Diesel 1,428,000 gallons 2,394,000 gallons 1,974,000 gallons Heating Oil 756,000 gallons 1,260,000 gallons 966,000 gallons Fair Values of Derivative Instruments The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows: Assets / (Liabilities) Derivatives Designated as Hedging Instruments Balance Sheet Location March 30, April 1, September 30, Interest rate swap agreements Prepaid and other current assets $ 13.6 $ 12.7 $ 16.7 Other assets 9.3 11.5 14.7 Other liabilities (0.8) — — Commodity hedging instruments Prepaid and other current assets — — 2.3 Other current liabilities — (0.4) — Total derivatives designated as hedging instruments $ 22.1 $ 23.8 $ 33.7 Derivatives Not Designated as Hedging Instruments Balance Sheet Location Currency forward contracts Prepaid and other current assets $ 0.4 $ — $ 5.6 Other current liabilities — (2.3) — Commodity hedging instruments Prepaid and other current assets — — 0.9 Other current liabilities — (0.4) — Total derivatives not designated as hedging instruments 0.4 (2.7) 6.5 Total derivatives $ 22.5 $ 21.1 $ 40.2 The effect of derivative instruments on AOCL, net of tax, and the Condensed Consolidated Statements of Operations for each of the periods presented was as follows: Derivatives in Cash Flow Hedging Relationships Amount of Gain / (Loss) Recognized in AOCL Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Interest rate swap agreements $ 5.8 $ (1.2) $ (0.6) $ (0.7) Commodity hedging instruments 0.3 (3.6) (1.5) (8.9) Total $ 6.1 $ (4.8) $ (2.1) $ (9.6) Derivatives in Cash Flow Hedging Relationships Reclassified from Amount of Gain / (Loss) Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Interest rate swap agreements Interest expense $ 4.1 $ 3.7 $ 6.7 $ 5.1 Commodity hedging instruments Cost of sales (3.2) 4.5 (4.3) 6.8 Total $ 0.9 $ 8.2 $ 2.4 $ 11.9 Derivatives Not Designated as Hedging Instruments Recognized in Amount of Gain / (Loss) Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Currency forward contracts Other income / expense, net $ 1.3 $ (5.3) $ (3.5) $ (16.6) Commodity hedging instruments Cost of sales (0.1) (0.6) (1.4) 0.9 Total $ 1.2 $ (5.9) $ (4.9) $ (15.7)

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
FAIR VALUE MEASUREMENTS	Mar. 30, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required: Fair Value March 30, April 1, September 30, Carrying Estimated Carrying Estimated Carrying Estimated Assets Cash equivalents Level 1 $ 28.1 $ 28.1 $ 2.9 $ 2.9 $ 1.2 $ 1.2 Other Investment securities in non-qualified retirement plan assets Level 1 42.3 42.3 39.0 39.0 36.3 36.3 Convertible debt investments Level 3 84.5 84.5 84.8 84.8 85.8 85.8 Liabilities Debt instruments Credit facilities – revolving loans Level 2 314.2 314.2 642.5 642.5 88.3 88.3 Credit facilities – term loans Level 2 900.0 900.0 950.0 950.0 925.0 925.0 Senior Notes due 2031 – 4.000% Level 2 500.0 427.5 500.0 398.8 500.0 380.0 Senior Notes due 2032 – 4.375% Level 2 400.0 344.0 400.0 320.5 400.0 304.0 Senior Notes due 2029 – 4.500% Level 2 450.0 405.0 450.0 388.1 450.0 366.8 Senior Notes due 2026 – 5.250% Level 2 250.0 245.6 250.0 238.8 250.0 233.1 Receivables facility Level 2 — — 380.0 380.0 — — Other debt Level 2 5.5 5.5 3.1 3.1 0.4 0.4 Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3. Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Fair value at beginning of period $ 85.0 $ 91.2 $ 85.8 $ 117.0 Total realized / unrealized gains included in net earnings 0.1 0.9 0.2 1.9 Total realized / unrealized losses included in OCI (0.6) (7.3) (1.5) (34.1) Fair value at end of period $ 84.5 $ 84.8 $ 84.5 $ 84.8 The amortized cost basis of convertible debt investments was $226.0, $224.0, and $225.8 at March 30, 2024, April 1, 2023, and September 30, 2023, respectively. At March 30, 2024, April 1, 2023, and September 30, 2023, gross unrealized losses on convertible debt investments were $141.4, $139.2, and $140.0 respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of March 30, 2024. The allowance for expected credit losses was $101.3, $0.0 and $101.3 at March 30, 2024, April 1, 2023 and September 30, 2023, respectively. At March 30, 2024, the period until scheduled maturity of the Company’s convertible debt investments was between 3.4 years and 5.5 years.

LEASES

LEASES	6 Months Ended
LEASES	Mar. 30, 2024
Leases [Abstract]
LEASES	LEASES The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At March 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $23.3. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the condensed consolidated financial statements for the three and six months ended March 30, 2024 and April 1, 2023. The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of March 30, 2024, the Company’s residual value guarantee would have approximated $5.2. Supplemental balance sheet information related to the Company’s leases was as follows: Balance Sheet Location March 30, April 1, September 30, Operating leases: Right-of-use assets Other assets $ 273.1 $ 255.9 $ 262.6 Current lease liabilities Other current liabilities 75.9 77.4 76.4 Non-current lease liabilities Other liabilities 223.7 203.2 220.1 Total operating lease liabilities $ 299.6 $ 280.6 $ 296.5 Finance leases: Right-of-use assets Property, plant and equipment, net $ 15.0 $ 15.7 $ 14.5 Current lease liabilities Current portion of debt 2.3 1.9 1.9 Non-current lease liabilities Long-term debt 15.2 16.0 15.0 Total finance lease liabilities $ 17.5 $ 17.9 $ 16.9 Components of lease cost were as follows: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Operating lease cost (a) $ 20.3 $ 23.9 $ 42.3 $ 46.1 Variable lease cost 9.2 7.1 15.8 13.6 Finance lease cost Amortization of right-of-use assets 0.6 0.6 1.2 2.0 Interest on lease liabilities 0.2 0.1 0.4 0.4 Total finance lease cost $ 0.8 $ 0.7 $ 1.6 $ 2.4 (a) Operating lease cost includes amortization of right-of-use assets of $16.5 and $34.7 for the three and six months ended March 30, 2024, respectively, and $23.8 and $42.8 for the three and six months ended April 1, 2023, respectively. Short-term lease expense is excluded from operating lease cost and is not material. Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows: Six Months Ended March 30, April 1, Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases, net $ 49.3 $ 46.3 Operating cash flows from finance leases 0.4 0.4 Financing cash flows from finance leases 1.0 1.8 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 41.6 $ 32.5 Finance leases 1.7 — Weighted-average remaining lease term and discount rate for the Company’s leases were as follows: March 30, April 1, September 30, Weighted-average remaining lease term (in years): Operating leases 5.4 4.8 5.4 Finance leases 8.7 9.8 9.5 Weighted-average discount rate: Operating leases 5.6 % 4.0 % 5.2 % Finance leases 4.6 % 4.4 % 4.4 % Maturities of lease liabilities by fiscal year for the Company’s leases as of March 30, 2024 were as follows: Year Operating Leases Finance Leases 2024 (remainder of the year) $ 47.8 $ 1.5 2025 82.8 3.0 2026 64.8 2.6 2027 40.8 2.2 2028 31.2 1.9 Thereafter 82.1 10.2 Total lease payments 349.5 21.4 Less: Imputed interest (49.9) (3.9) Total lease liabilities $ 299.6 $ 17.5
LEASES	LEASES The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At March 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $23.3. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the condensed consolidated financial statements for the three and six months ended March 30, 2024 and April 1, 2023. The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of March 30, 2024, the Company’s residual value guarantee would have approximated $5.2. Supplemental balance sheet information related to the Company’s leases was as follows: Balance Sheet Location March 30, April 1, September 30, Operating leases: Right-of-use assets Other assets $ 273.1 $ 255.9 $ 262.6 Current lease liabilities Other current liabilities 75.9 77.4 76.4 Non-current lease liabilities Other liabilities 223.7 203.2 220.1 Total operating lease liabilities $ 299.6 $ 280.6 $ 296.5 Finance leases: Right-of-use assets Property, plant and equipment, net $ 15.0 $ 15.7 $ 14.5 Current lease liabilities Current portion of debt 2.3 1.9 1.9 Non-current lease liabilities Long-term debt 15.2 16.0 15.0 Total finance lease liabilities $ 17.5 $ 17.9 $ 16.9 Components of lease cost were as follows: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Operating lease cost (a) $ 20.3 $ 23.9 $ 42.3 $ 46.1 Variable lease cost 9.2 7.1 15.8 13.6 Finance lease cost Amortization of right-of-use assets 0.6 0.6 1.2 2.0 Interest on lease liabilities 0.2 0.1 0.4 0.4 Total finance lease cost $ 0.8 $ 0.7 $ 1.6 $ 2.4 (a) Operating lease cost includes amortization of right-of-use assets of $16.5 and $34.7 for the three and six months ended March 30, 2024, respectively, and $23.8 and $42.8 for the three and six months ended April 1, 2023, respectively. Short-term lease expense is excluded from operating lease cost and is not material. Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows: Six Months Ended March 30, April 1, Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases, net $ 49.3 $ 46.3 Operating cash flows from finance leases 0.4 0.4 Financing cash flows from finance leases 1.0 1.8 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 41.6 $ 32.5 Finance leases 1.7 — Weighted-average remaining lease term and discount rate for the Company’s leases were as follows: March 30, April 1, September 30, Weighted-average remaining lease term (in years): Operating leases 5.4 4.8 5.4 Finance leases 8.7 9.8 9.5 Weighted-average discount rate: Operating leases 5.6 % 4.0 % 5.2 % Finance leases 4.6 % 4.4 % 4.4 % Maturities of lease liabilities by fiscal year for the Company’s leases as of March 30, 2024 were as follows: Year Operating Leases Finance Leases 2024 (remainder of the year) $ 47.8 $ 1.5 2025 82.8 3.0 2026 64.8 2.6 2027 40.8 2.2 2028 31.2 1.9 Thereafter 82.1 10.2 Total lease payments 349.5 21.4 Less: Imputed interest (49.9) (3.9) Total lease liabilities $ 299.6 $ 17.5

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
SEGMENT INFORMATION	Mar. 30, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Hawthorne consists of the Company’s indoor and hydroponic gardening business. Other primarily consists of the Company’s consumer lawn and garden business in Canada. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. The performance of each reportable segment is evaluated based on several factors, including income (loss) before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment. The following tables present financial information for the Company’s reportable segments for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net Sales: U.S. Consumer $ 1,379.8 $ 1,357.4 $ 1,686.5 $ 1,726.3 Hawthorne 66.4 92.7 146.6 224.2 Other 79.2 81.4 102.7 107.6 Consolidated $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1 Segment Profit (Loss): U.S. Consumer $ 385.7 $ 397.4 $ 370.3 $ 428.7 Hawthorne (3.4) (16.8) (13.0) (33.0) Other 6.4 14.6 1.2 16.0 Total Segment Profit 388.7 395.2 358.5 411.7 Corporate (35.7) (42.1) (61.7) (74.0) Intangible asset amortization (3.9) (6.4) (7.9) (14.1) Impairment, restructuring and other (77.0) (140.5) (64.1) (159.2) Equity in loss of unconsolidated affiliates (7.0) (7.3) (29.5) (18.7) Interest expense (44.1) (48.3) (86.8) (91.0) Other non-operating income (expense), net (1.2) (0.8) (2.9) 0.8 Income before income taxes $ 219.8 $ 149.8 $ 105.6 $ 55.5 The following table presents net sales by product category for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, U.S. Consumer: Growing media and mulch $ 591.5 $ 517.2 $ 663.5 $ 614.3 Lawn care 509.8 534.3 628.6 679.7 Controls 137.1 134.6 190.5 192.8 Roundup ® marketing agreement 64.6 70.7 88.0 91.0 Other, primarily gardening 76.8 100.6 115.9 148.5 Hawthorne: Lighting 16.1 18.1 48.0 68.4 Nutrients 24.6 24.4 41.2 47.2 Growing media 10.2 18.5 21.4 36.3 Growing environments 6.3 16.0 17.8 41.5 Other, primarily hardware 9.2 15.7 18.2 30.8 Other: Growing media 23.3 24.9 36.5 40.3 Lawn care 31.5 29.7 33.8 32.3 Other, primarily gardening and controls 24.4 26.8 32.4 35.0 Total net sales $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1 The following table presents net sales by geographic area for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net sales: United States $ 1,441.7 $ 1,447.2 $ 1,807.5 $ 1,912.2 International 83.7 84.3 128.3 145.9 $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
Insider Trading Arrangements	Mar. 30, 2024 shares	Mar. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Katherine Littlefield [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On March 15, 2024, the Hagedorn Partnership, L.P., on behalf of Katherine Littlefield, a member of our board of directors, adopted a Rule 10b5-1 plan providing for the sale of up to 250,000 Common Shares. Pursuant to this plan, if certain price targets are met, the Hagedorn Partnership, L.P. may sell Common Shares beginning on the later of (i) June 14, 2024 or (ii) the natural expiration of the trading plan entered into on September 5, 2023 by the Hagedorn Partnership, L.P., on behalf of Ms. Littlefield, and ending December 5, 2025. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c).
Name	Katherine Littlefield
Title	board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 15, 2024
Arrangement Duration	539 days
Aggregate Available	250,000	250,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Mar. 30, 2024
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia. The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.
Organization and Basis of Presentation	Organization and Basis of Presentation The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 30, 2024 and April 1, 2023 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the condensed consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this Quarterly Report on Form 10-Q for the fiscal quarter ended March 30, 2024 (this “Form 10-Q”) should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Supplier Finance Program	Supplier Finance Program
Recently Adopted & Issued Accounting Pronouncements	RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information , which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Mar. 30, 2024
Accounting Policies [Abstract]
Schedule of Supplemental Cash Flow Information	Supplemental cash flow information was as follows: Six Months Ended March 30, April 1, Interest paid $ 83.6 $ 87.4 Income taxes paid (refunded), net — (21.1)

IMPAIRMENT, RESTRUCTURING AND_2

IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)	6 Months Ended
IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)	Mar. 30, 2024
Restructuring and Related Activities [Abstract]
Schedules of Impairment, Restructuring and Other Charges, and Activity Related to Liabilities	The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Cost of sales—impairment, restructuring and other: Restructuring and other charges, net $ 70.1 $ 99.9 $ 64.0 $ 105.6 Right-of-use asset impairments 0.7 14.1 0.9 15.4 Property, plant and equipment impairments 4.1 4.7 4.2 8.0 Operating expenses—impairment, restructuring and other: Restructuring and other charges (recoveries), net 2.1 21.8 (5.0) 30.2 Total impairment, restructuring and other charges, net $ 77.0 $ 140.5 $ 64.1 $ 159.2 The following table summarizes the activity related to liabilities associated with restructuring activities during the six months ended March 30, 2024: Amounts accrued at September 30, 2023 $ 40.5 Restructuring charges 7.0 Payments (16.3) Amounts accrued at March 30, 2024 $ 31.2

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
INVENTORIES (Tables)	Mar. 30, 2024
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories consisted of the following for each of the periods presented: March 30, April 1, September 30, Finished goods $ 480.9 $ 759.0 $ 506.2 Raw materials 261.3 279.0 272.5 Work-in-process 82.1 89.6 101.6 Total inventories, net $ 824.3 $ 1,127.6 $ 880.3

MARKETING AGREEMENT (Tables)

MARKETING AGREEMENT (Tables)	6 Months Ended
MARKETING AGREEMENT (Tables)	Mar. 30, 2024
Marketing Agreement [Abstract]
Schedule of Net Commission and Reimbursements Earned Under Marketing Agreement	The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Condensed Consolidated Statements of Operations are as follows: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Gross commission $ 40.6 $ 48.9 $ 49.5 $ 58.5 Contribution expenses (4.5) (4.5) (9.0) (9.0) Net commission 36.1 44.4 40.5 49.5 Reimbursements associated with Roundup ® marketing agreement 29.0 27.2 48.1 42.4 Total net sales associated with Roundup ® marketing agreement $ 65.1 $ 71.6 $ 88.6 $ 91.9

DEBT (Tables)

DEBT (Tables)	6 Months Ended
DEBT (Tables)	Mar. 30, 2024
Debt Disclosure [Abstract]
Components of Long-Term Debt	The components of debt are as follows: March 30, April 1, September 30, Credit Facilities: Revolving loans $ 314.2 $ 642.5 $ 88.3 Term loans 900.0 950.0 925.0 Senior Notes due 2031 – 4.000% 500.0 500.0 500.0 Senior Notes due 2032 – 4.375% 400.0 400.0 400.0 Senior Notes due 2029 – 4.500% 450.0 450.0 450.0 Senior Notes due 2026 – 5.250% 250.0 250.0 250.0 Receivables facility — 380.0 — Finance lease obligations 17.5 17.9 16.9 Other 5.5 3.1 0.4 Total debt 2,837.2 3,593.5 2,630.6 Less current portions 57.8 435.4 52.3 Less unamortized debt issuance costs 18.9 20.1 20.9 Long-term debt $ 2,760.5 $ 3,138.0 $ 2,557.4
Schedule of Interest Rate Swap Agreements	The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at March 30, 2024 are shown in the table below: Notional Effective Expiration Fixed 200 (b) 1/20/2022 6/20/2024 0.49 % 200 6/7/2023 6/8/2026 0.80 % 150 6/7/2023 4/7/2027 3.37 % 50 6/7/2023 4/7/2027 3.34 % 100 (b) 11/20/2023 3/22/2027 4.74 % (a) The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement. (b) Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

EQUITY (Tables)

EQUITY (Tables)	6 Months Ended
EQUITY (Tables)	Mar. 30, 2024
Equity [Abstract]
Summary of Changes in Equity (Deficit)	The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated: Common Shares Retained Treasury Accumulated Other Total Balance at September 30, 2023 $ 353.1 $ 490.9 $ (998.5) $ (112.8) $ (267.3) Net income (loss) — (80.5) — — (80.5) Other comprehensive income (loss) — — — (8.9) (8.9) Share-based compensation 11.7 — — — 11.7 Dividends declared ($0.66 per share) — (38.0) — — (38.0) Treasury share purchases — — (3.1) — (3.1) Treasury share issuances (15.2) — 15.9 — 0.7 Balance at December 30, 2023 349.6 372.4 (985.7) (121.7) (385.4) Net income (loss) — 157.5 — — 157.5 Other comprehensive income (loss) — — — 3.0 3.0 Share-based compensation 12.4 — — — 12.4 Dividends declared ($0.66 per share) — (38.1) — — (38.1) Treasury share purchases — — (1.7) — (1.7) Treasury share issuances (8.3) — 9.6 — 1.3 Balance at March 30, 2024 $ 353.7 $ 491.8 $ (977.8) $ (118.6) $ (250.9) The sum of the components may not equal due to rounding. Common Shares Retained Treasury Accumulated Other Total Balance at September 30, 2022 $ 364.0 $ 1,020.1 $ (1,091.8) $ (144.6) $ 147.7 Net income (loss) — (64.7) — — (64.7) Other comprehensive income (loss) — — — (24.6) (24.6) Share-based compensation 20.8 — — — 20.8 Dividends declared ($0.66 per share) — (37.5) — — (37.5) Treasury share purchases — — (0.8) — (0.8) Treasury share issuances (17.2) — 35.9 — 18.7 Balance at December 31, 2022 367.6 917.9 (1,056.7) (169.3) 59.5 Net income (loss) — 109.4 — — 109.4 Other comprehensive income (loss) — — — (17.8) (17.8) Share-based compensation 37.2 — — — 37.2 Dividends declared ($0.66 per share) — (37.0) — — (37.0) Treasury share purchases — — (5.6) — (5.6) Treasury share issuances (30.4) — 22.3 — (8.1) Balance at April 1, 2023 $ 374.3 $ 990.3 $ (1,040.0) $ (187.1) $ 137.5 The sum of the components may not equal due to rounding.
Schedule of Accumulated Other Comprehensive Loss	Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated: Three Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) Pension and Other Post-Retirement Accumulated Other Balance at December 30, 2023 $ (18.8) $ 10.4 $ (39.5) $ (73.8) $ (121.7) Other comprehensive income (loss) before reclassifications (2.6) 8.2 (0.6) — 5.0 Amounts reclassified from accumulated other comprehensive net income (loss) — (1.2) — 1.6 0.4 Income tax benefit (expense) — (1.8) — (0.6) (2.4) Net current period other comprehensive income (loss) (2.6) 5.2 (0.6) 1.0 3.0 Balance at March 30, 2024 $ (21.4) $ 15.7 $ (40.1) $ (72.9) $ (118.6) Balance at December 31, 2022 $ (21.7) $ 24.8 $ (100.2) $ (72.2) $ (169.3) Other comprehensive income (loss) before reclassifications 1.1 (6.4) (7.3) — (12.6) Amounts reclassified from accumulated other comprehensive net income (loss) — (11.0) — (0.4) (11.4) Income tax benefit (expense) — 4.4 1.7 0.1 6.2 Net current period other comprehensive income (loss) 1.1 (13.0) (5.6) (0.3) (17.8) Balance at April 1, 2023 $ (20.7) $ 11.8 $ (105.7) $ (72.6) $ (187.1) The sum of the components may not equal due to rounding. Six Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) Pension and Other Post-Retirement Accumulated Other Balance at September 30, 2023 $ (21.9) $ 20.1 $ (38.6) $ (72.4) $ (112.8) Other comprehensive income (loss) before reclassifications 0.5 (2.8) (1.5) — (3.8) Amounts reclassified from accumulated other comprehensive net income (loss) — (3.2) — (0.5) (3.7) Income tax benefit (expense) — 1.5 — 0.1 1.6 Net current period other comprehensive income (loss) 0.5 (4.5) (1.5) (0.4) (5.9) Balance at March 30, 2024 $ (21.4) $ 15.7 $ (40.1) $ (72.9) $ (118.6) Balance at September 30, 2022 $ (28.9) $ 33.3 $ (79.7) $ (69.3) $ (144.6) Other comprehensive income (loss) before reclassifications 8.3 (12.9) (34.1) — (38.7) Amounts reclassified from accumulated other comprehensive net income (loss) — (16.0) — (4.3) (20.3) Income tax benefit (expense) — 7.4 8.1 1.1 16.6 Net current period other comprehensive income (loss) 8.3 (21.5) (26.0) (3.2) (42.4) Balance at April 1, 2023 $ (20.7) $ 11.8 $ (105.7) $ (72.6) $ (187.1) The sum of the components may not equal due to rounding.
Schedule of Share-Based Compensation	Total share-based compensation was as follows for each of the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Share-based compensation $ 28.1 $ 37.2 $ 44.1 $ 57.9 Related tax benefit recognized 4.6 6.1 7.2 10.8
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award	The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant. Details of the assumptions used in the Monte Carlo simulation model are as follows: Expected volatility 36.6 % Risk-free interest rate 4.5 %
Schedule of Performance-based Award Activity	Performance-based award activity was as follows (based on target award amounts): No. of Wtd. Avg. Grant Date Awards outstanding at September 30, 2023 544,790 $ 76.85 Granted 232,801 74.95 Vested (a) (181,791) 59.88 Forfeited (185,740) 64.66 Awards outstanding at March 30, 2024 410,060 87.03 (a) Vested at a weighted average of 100% of the target performance share units granted.

EARNINGS PER COMMON SHARE (Tabl

EARNINGS PER COMMON SHARE (Tables)	6 Months Ended
EARNINGS PER COMMON SHARE (Tables)	Mar. 30, 2024
Earnings Per Share [Abstract]
Information to Calculate Basic and Diluted Earnings (Loss) Per Common Share	The following table presents information necessary to calculate basic and diluted net income per Common Share for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net income $ 157.5 $ 109.4 $ 77.0 $ 44.7 Basic net income per common share Weighted-average common shares outstanding during the period 56.8 56.0 56.7 55.8 Basic net income per common share $ 2.77 $ 1.95 $ 1.36 $ 0.80 Diluted net income per common share Weighted-average common shares outstanding during the period 56.8 56.0 56.7 55.8 Dilutive potential common shares 0.6 0.5 0.6 0.3 Weighted-average common shares outstanding during the period plus dilutive potential common shares 57.4 56.5 57.3 56.1 Diluted net income per common share $ 2.74 $ 1.94 $ 1.34 $ 0.80 Antidilutive stock options outstanding 0.4 0.2 0.6 0.3

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	6 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	Mar. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Outstanding Derivative Contracts	The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases: Commodity March 30, April 1, September 30, Urea — 19,500 tons 52,500 tons Diesel 1,428,000 gallons 2,394,000 gallons 1,974,000 gallons Heating Oil 756,000 gallons 1,260,000 gallons 966,000 gallons
Schedule of the Fair Values of Derivative Instruments	The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows: Assets / (Liabilities) Derivatives Designated as Hedging Instruments Balance Sheet Location March 30, April 1, September 30, Interest rate swap agreements Prepaid and other current assets $ 13.6 $ 12.7 $ 16.7 Other assets 9.3 11.5 14.7 Other liabilities (0.8) — — Commodity hedging instruments Prepaid and other current assets — — 2.3 Other current liabilities — (0.4) — Total derivatives designated as hedging instruments $ 22.1 $ 23.8 $ 33.7 Derivatives Not Designated as Hedging Instruments Balance Sheet Location Currency forward contracts Prepaid and other current assets $ 0.4 $ — $ 5.6 Other current liabilities — (2.3) — Commodity hedging instruments Prepaid and other current assets — — 0.9 Other current liabilities — (0.4) — Total derivatives not designated as hedging instruments 0.4 (2.7) 6.5 Total derivatives $ 22.5 $ 21.1 $ 40.2
Schedule of the Effect of Derivative Instruments on AOCL and Statements of Operations	The effect of derivative instruments on AOCL, net of tax, and the Condensed Consolidated Statements of Operations for each of the periods presented was as follows: Derivatives in Cash Flow Hedging Relationships Amount of Gain / (Loss) Recognized in AOCL Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Interest rate swap agreements $ 5.8 $ (1.2) $ (0.6) $ (0.7) Commodity hedging instruments 0.3 (3.6) (1.5) (8.9) Total $ 6.1 $ (4.8) $ (2.1) $ (9.6) Derivatives in Cash Flow Hedging Relationships Reclassified from Amount of Gain / (Loss) Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Interest rate swap agreements Interest expense $ 4.1 $ 3.7 $ 6.7 $ 5.1 Commodity hedging instruments Cost of sales (3.2) 4.5 (4.3) 6.8 Total $ 0.9 $ 8.2 $ 2.4 $ 11.9 Derivatives Not Designated as Hedging Instruments Recognized in Amount of Gain / (Loss) Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Currency forward contracts Other income / expense, net $ 1.3 $ (5.3) $ (3.5) $ (16.6) Commodity hedging instruments Cost of sales (0.1) (0.6) (1.4) 0.9 Total $ 1.2 $ (5.9) $ (4.9) $ (15.7)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Mar. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring Basis	The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required: Fair Value March 30, April 1, September 30, Carrying Estimated Carrying Estimated Carrying Estimated Assets Cash equivalents Level 1 $ 28.1 $ 28.1 $ 2.9 $ 2.9 $ 1.2 $ 1.2 Other Investment securities in non-qualified retirement plan assets Level 1 42.3 42.3 39.0 39.0 36.3 36.3 Convertible debt investments Level 3 84.5 84.5 84.8 84.8 85.8 85.8 Liabilities Debt instruments Credit facilities – revolving loans Level 2 314.2 314.2 642.5 642.5 88.3 88.3 Credit facilities – term loans Level 2 900.0 900.0 950.0 950.0 925.0 925.0 Senior Notes due 2031 – 4.000% Level 2 500.0 427.5 500.0 398.8 500.0 380.0 Senior Notes due 2032 – 4.375% Level 2 400.0 344.0 400.0 320.5 400.0 304.0 Senior Notes due 2029 – 4.500% Level 2 450.0 405.0 450.0 388.1 450.0 366.8 Senior Notes due 2026 – 5.250% Level 2 250.0 245.6 250.0 238.8 250.0 233.1 Receivables facility Level 2 — — 380.0 380.0 — — Other debt Level 2 5.5 5.5 3.1 3.1 0.4 0.4
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3. Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Fair value at beginning of period $ 85.0 $ 91.2 $ 85.8 $ 117.0 Total realized / unrealized gains included in net earnings 0.1 0.9 0.2 1.9 Total realized / unrealized losses included in OCI (0.6) (7.3) (1.5) (34.1) Fair value at end of period $ 84.5 $ 84.8 $ 84.5 $ 84.8

LEASES (Tables)

LEASES (Tables)	6 Months Ended
LEASES (Tables)	Mar. 30, 2024
Leases [Abstract]
Weighted-Average Remaining Lease Term and Discount Rate and Supplemental Balance Sheet Information Schedule	Supplemental balance sheet information related to the Company’s leases was as follows: Balance Sheet Location March 30, April 1, September 30, Operating leases: Right-of-use assets Other assets $ 273.1 $ 255.9 $ 262.6 Current lease liabilities Other current liabilities 75.9 77.4 76.4 Non-current lease liabilities Other liabilities 223.7 203.2 220.1 Total operating lease liabilities $ 299.6 $ 280.6 $ 296.5 Finance leases: Right-of-use assets Property, plant and equipment, net $ 15.0 $ 15.7 $ 14.5 Current lease liabilities Current portion of debt 2.3 1.9 1.9 Non-current lease liabilities Long-term debt 15.2 16.0 15.0 Total finance lease liabilities $ 17.5 $ 17.9 $ 16.9 Weighted-average remaining lease term and discount rate for the Company’s leases were as follows: March 30, April 1, September 30, Weighted-average remaining lease term (in years): Operating leases 5.4 4.8 5.4 Finance leases 8.7 9.8 9.5 Weighted-average discount rate: Operating leases 5.6 % 4.0 % 5.2 % Finance leases 4.6 % 4.4 % 4.4 %
Lease Cost Components and Supplemental Cash Flow Information and Non-Cash Activity For Company's Leases Schedules	Components of lease cost were as follows: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Operating lease cost (a) $ 20.3 $ 23.9 $ 42.3 $ 46.1 Variable lease cost 9.2 7.1 15.8 13.6 Finance lease cost Amortization of right-of-use assets 0.6 0.6 1.2 2.0 Interest on lease liabilities 0.2 0.1 0.4 0.4 Total finance lease cost $ 0.8 $ 0.7 $ 1.6 $ 2.4 (a) Operating lease cost includes amortization of right-of-use assets of $16.5 and $34.7 for the three and six months ended March 30, 2024, respectively, and $23.8 and $42.8 for the three and six months ended April 1, 2023, respectively. Short-term lease expense is excluded from operating lease cost and is not material. Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows: Six Months Ended March 30, April 1, Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases, net $ 49.3 $ 46.3 Operating cash flows from finance leases 0.4 0.4 Financing cash flows from finance leases 1.0 1.8 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 41.6 $ 32.5 Finance leases 1.7 —
Maturities of Operating Lease Liabilities by Fiscal Year Schedule	Maturities of lease liabilities by fiscal year for the Company’s leases as of March 30, 2024 were as follows: Year Operating Leases Finance Leases 2024 (remainder of the year) $ 47.8 $ 1.5 2025 82.8 3.0 2026 64.8 2.6 2027 40.8 2.2 2028 31.2 1.9 Thereafter 82.1 10.2 Total lease payments 349.5 21.4 Less: Imputed interest (49.9) (3.9) Total lease liabilities $ 299.6 $ 17.5
Maturities of Finance Lease Liabilities by Fiscal Year Schedule	Maturities of lease liabilities by fiscal year for the Company’s leases as of March 30, 2024 were as follows: Year Operating Leases Finance Leases 2024 (remainder of the year) $ 47.8 $ 1.5 2025 82.8 3.0 2026 64.8 2.6 2027 40.8 2.2 2028 31.2 1.9 Thereafter 82.1 10.2 Total lease payments 349.5 21.4 Less: Imputed interest (49.9) (3.9) Total lease liabilities $ 299.6 $ 17.5

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	6 Months Ended
SEGMENT INFORMATION (Tables)	Mar. 30, 2024
Segment Reporting [Abstract]
Summary of Segment Financial Information	The following tables present financial information for the Company’s reportable segments for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net Sales: U.S. Consumer $ 1,379.8 $ 1,357.4 $ 1,686.5 $ 1,726.3 Hawthorne 66.4 92.7 146.6 224.2 Other 79.2 81.4 102.7 107.6 Consolidated $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1 Segment Profit (Loss): U.S. Consumer $ 385.7 $ 397.4 $ 370.3 $ 428.7 Hawthorne (3.4) (16.8) (13.0) (33.0) Other 6.4 14.6 1.2 16.0 Total Segment Profit 388.7 395.2 358.5 411.7 Corporate (35.7) (42.1) (61.7) (74.0) Intangible asset amortization (3.9) (6.4) (7.9) (14.1) Impairment, restructuring and other (77.0) (140.5) (64.1) (159.2) Equity in loss of unconsolidated affiliates (7.0) (7.3) (29.5) (18.7) Interest expense (44.1) (48.3) (86.8) (91.0) Other non-operating income (expense), net (1.2) (0.8) (2.9) 0.8 Income before income taxes $ 219.8 $ 149.8 $ 105.6 $ 55.5 The following table presents net sales by product category for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, U.S. Consumer: Growing media and mulch $ 591.5 $ 517.2 $ 663.5 $ 614.3 Lawn care 509.8 534.3 628.6 679.7 Controls 137.1 134.6 190.5 192.8 Roundup ® marketing agreement 64.6 70.7 88.0 91.0 Other, primarily gardening 76.8 100.6 115.9 148.5 Hawthorne: Lighting 16.1 18.1 48.0 68.4 Nutrients 24.6 24.4 41.2 47.2 Growing media 10.2 18.5 21.4 36.3 Growing environments 6.3 16.0 17.8 41.5 Other, primarily hardware 9.2 15.7 18.2 30.8 Other: Growing media 23.3 24.9 36.5 40.3 Lawn care 31.5 29.7 33.8 32.3 Other, primarily gardening and controls 24.4 26.8 32.4 35.0 Total net sales $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1 The following table presents net sales by geographic area for the periods indicated: Three Months Ended Six Months Ended March 30, April 1, March 30, April 1, Net sales: United States $ 1,441.7 $ 1,447.2 $ 1,807.5 $ 1,912.2 International 83.7 84.3 128.3 145.9 $ 1,525.4 $ 1,531.5 $ 1,935.8 $ 2,058.1

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Mar. 30, 2024	Mar. 30, 2024	Apr. 01, 2023	Oct. 27, 2023	Sep. 30, 2023
Line of Credit Facility [Line Items]
Percentage of annual net sales		75%
Noncash investing activities for unpaid liabilities incurred		$ 10.1	$ 15.3
Proceeds from loans receivable		0	37
Accounts Receivable, Held-for-Sale				$ 600
Increase (Decrease) in Receivables		582.8
Proceeds from Sale of Other Receivables	$ 758.2	955.5
Discount On Sale Of Other Receivables	10.7	12.9
Supplier Finance Program, Obligation	$ 38.5	38.5	31		$ 18.3
Supplier Finance Program, Obligation, Settlement		$ 153	$ 110.3
Minimum
Line of Credit Facility [Line Items]
Supplier Finance Program, Payment Timing, Period	30 days	30 days
Maximum
Line of Credit Facility [Line Items]
Supplier Finance Program, Payment Timing, Period	60 days	60 days
Standby Letters of Credit
Line of Credit Facility [Line Items]
Senior secured credit facilities, maximum borrowing capacity				$ 70

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Accounting Policies [Abstract]
Interest paid	$ 83.6	$ 87.4
Income taxes paid (refunded), net	$ 0	$ (21.1)

INVESTMENT IN UNCONSOLIDATED _2

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Nov. 07, 2023	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023	Dec. 31, 2022	Dec. 31, 2020
Investments in and Advances to Affiliates [Line Items]
Equity in loss of unconsolidated affiliates		$ 7	$ 7.3	$ 29.5	$ 18.7
Bonnie Plants
Investments in and Advances to Affiliates [Line Items]
Equity ownership percentage	50%					45%	50%
Equity Method Investment, Ownership Percentage Increase (Decrease)	5%
Payments to acquire equity interest	$ 21.4
Equity Method Investment, Non-Cash Impairment, Before Tax		$ 0		$ 10.4

IMPAIRMENT, RESTRUCTURING AND_3

IMPAIRMENT, RESTRUCTURING AND OTHER - Impairment, Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries), net	$ 2.1	$ 21.8	$ (5)	$ 30.2
Total impairment, restructuring and other charges, net	77	140.5	64.1	159.2
Restructuring and other charges, net \| Cost of sales—impairment, restructuring and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries), net	70.1	99.9	64	105.6
Restructuring and other charges, net \| Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries), net	2.1	21.8	(5)	30.2
Right-of-use asset impairments \| Cost of sales—impairment, restructuring and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries), net	0.7	14.1	0.9	15.4
Property, plant and equipment impairments \| Cost of sales—impairment, restructuring and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries), net	$ 4.1	$ 4.7	$ 4.2	$ 8

IMPAIRMENT, RESTRUCTURING AND_4

IMPAIRMENT, RESTRUCTURING AND OTHER - Activity Related to Liabilities Associated with Restructuring (Details) $ in Millions	6 Months Ended
	Mar. 30, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Amounts accrued for restructuring and other, beginning balance	$ 40.5
Restructuring charges	7
Payments	(16.3)
Amounts accrued for restructuring and other, ending balance	$ 31.2

IMPAIRMENT, RESTRUCTURING AND_5

IMPAIRMENT, RESTRUCTURING AND OTHER - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, long-term	$ 9.2		$ 9.2
Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments		$ 136.8		$ 151.4
Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	77		73.2
U.S. Consumer
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments			46
Hawthorne
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments			294.4
Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments			1.8
Corporate Segment \| Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments			25.1
Cost of sales—impairment, restructuring and other \| U.S. Consumer
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	(0.5)	0.2	1.4	1.2
Cost of sales—impairment, restructuring and other \| Hawthorne
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	75.4	118.5	67.8	127
Impairment, Restructuring, And Other \| U.S. Consumer
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	(0.1)	0.1	(0.9)	0.3
Impairment, Restructuring, And Other \| Hawthorne
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	1.9	17.1	2.3	18.2
Impairment, Restructuring, And Other \| Other
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	0.2		0.3
Impairment, Restructuring, And Other \| Corporate Segment
Restructuring Cost and Reserve [Line Items]
Restructuring charges and adjustments	0	$ 0.8	2.4	$ 4.5
Restructuring, Settlement And Impairment Provisions
Restructuring Cost and Reserve [Line Items]
(Gain) Loss on Disposition of Property Plant Equipment	$ 0		$ (12.1)

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 480.9	$ 506.2	$ 759
Raw materials	261.3	272.5	279
Work-in-process	82.1	101.6	89.6
Total inventories, net	$ 824.3	$ 880.3	$ 1,127.6

MARKETING AGREEMENT - Additiona

MARKETING AGREEMENT - Additional Information (Details) $ in Millions	Aug. 01, 2019 USD ($)
Restated Marketing Agreement
Marketing Agreement [Line Items]
Percentage of program earnings	50%
Annual payments	$ 18
Third Restated Agreement
Marketing Agreement [Line Items]
Minimum annual EBIT required to avoid reduction of contribution payment	36
Minimum EBIT	50
Brand decommissioning event payable	375
Termination fee payable	$ 175
Minimum termination fee payable multiple	4
Minimum termination fee payable threshold	$ 186.4

MARKETING AGREEMENT - Net Commi

MARKETING AGREEMENT - Net Commission Earned Under Marketing Agreement (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Marketing Agreement [Line Items]
Contribution expenses	$ (986.8)	$ (1,000.1)	$ (1,340.8)	$ (1,420.7)
Restated Marketing Agreement
Marketing Agreement [Line Items]
Gross commission	40.6	48.9	49.5	58.5
Contribution expenses	(4.5)	(4.5)	(9)	(9)
Net commission	36.1	44.4	40.5	49.5
Reimbursements associated with Roundup® marketing agreement	29	27.2	48.1	42.4
Total net sales associated with Roundup® marketing agreement	$ 65.1	$ 71.6	$ 88.6	$ 91.9

DEBT - Components of Long-Term

DEBT - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Debt Instrument [Line Items]
Total debt	$ 2,837.2	$ 2,630.6	$ 3,593.5
Less current portions	57.8	52.3	435.4
Long-term debt	2,760.5	2,557.4	3,138
Credit Facilities \| Revolving loans
Debt Instrument [Line Items]
Total debt	314.2	88.3	642.5
Credit Facilities \| Term loans
Debt Instrument [Line Items]
Total debt	$ 900	$ 925	$ 950
Senior Notes \| 4.000% Senior Notes Due 2031
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4%	4%	4%		4%
Total debt	$ 500	$ 500	$ 500
Senior Notes \| 4.375% Senior Notes Due 2032
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.375%	4.375%	4.375%	4.375%
Total debt	$ 400	$ 400	$ 400
Senior Notes \| 4.500% Senior Notes Due 2029
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.50%	4.50%	4.50%			4.50%
Total debt	$ 450	$ 450	$ 450
Senior Notes \| 5.250% Senior Notes Due 2026
Debt Instrument [Line Items]
Interest rate of debt (percentage)	5.25%	5.25%	5.25%				5.25%
Total debt	$ 250	$ 250	$ 250
Receivables facility
Debt Instrument [Line Items]
Total debt	0	0	380
Finance lease obligations
Debt Instrument [Line Items]
Total debt	17.5	16.9	17.9
Other
Debt Instrument [Line Items]
Total debt	5.5	0.4	3.1
Long-term debt
Debt Instrument [Line Items]
Less unamortized debt issuance costs	$ 18.9	$ 20.9	$ 20.1

DEBT - Credit Facilities (Detai

DEBT - Credit Facilities (Details) $ in Millions	Jul. 31, 2023 USD ($)	Apr. 08, 2022 USD ($)	Mar. 30, 2024 USD ($)	Apr. 01, 2023	Jun. 08, 2022
Debt Instrument [Line Items]
Weighted average interest rate (percentage)			5.90%	5.30%
Leverage ratio			6.95
Debt Instrument, Covenant, Fixed Charge Coverage Ratio			0.95
Period One
Debt Instrument [Line Items]
Debt instrument, leverage ratio			7.75
Interest coverage ratio			0.75
Period Two
Debt Instrument [Line Items]
Debt instrument, leverage ratio			6.50
Interest coverage ratio			1
Period Three
Debt Instrument [Line Items]
Debt instrument, leverage ratio			6
Period Four
Debt Instrument [Line Items]
Debt instrument, leverage ratio			5.50
Period Five
Debt Instrument [Line Items]
Debt instrument, leverage ratio			5.25
Period six
Debt Instrument [Line Items]
Debt instrument, leverage ratio			5
Period seven
Debt Instrument [Line Items]
Debt instrument, leverage ratio			4.75
Period eight
Debt Instrument [Line Items]
Debt instrument, leverage ratio			4.50
Revolving Credit Facility
Debt Instrument [Line Items]
Weighted average interest rate (percentage)			8.90%	7%
Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		$ 2,500
Long-Term Debt			$ 2,814.2
Sixth Amended And Restated Senior Secured Credit Agreement \| Revolving Credit Facility
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		1,500
Letters of credit		100
Sixth Amended And Restated Senior Secured Credit Agreement \| Secured Term Loan
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		$ 1,000
Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One \| Revolving Credit Facility
Debt Instrument [Line Items]
Increase in interest rate, bps					35
Increase in annual facility fee rate, bps					15
Debt instrument, leverage ratio					4.75
Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One \| Secured Term Loan
Debt Instrument [Line Items]
Increase in interest rate, bps					50
Sixth Amended And Restated Senior Secured Credit Agreement, Amendment Two \| Revolving Credit Facility
Debt Instrument [Line Items]
Reduction of commitments	$ 250
Interest rate increase (decrease)	0.25%
Incremental investments, loans, and advances, maximum	$ 25
Common stock cash dividends, maximum per fiscal year	225
Other dividends and distributions, maximum	$ 25
Debt Instrument, Covenant, Leverage Ratio, Minimum Threshold For Additional Pricing Tier	6
Credit Facilities
Debt Instrument [Line Items]
Available borrowing capacity			857.8
Credit Facilities \| Letter of Credit
Debt Instrument [Line Items]
Principal amount			$ 78
Credit Facilities \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Debt, maturity period (years)		5 years

DEBT - Senior Notes (Details)

DEBT - Senior Notes (Details) - Senior notes - USD ($) $ in Millions	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023	Aug. 13, 2021
Debt Instrument [Line Items]
Interest coverage ratio				2
Debt Instrument, Covenant, Interest Coverage Ratio				2.48
5.250% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)			5.25%	5.25%	5.25%	5.25%
Proceeds from issuance of unsecured debt			$ 250
4.500% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)		4.50%		4.50%	4.50%	4.50%
Proceeds from issuance of unsecured debt		$ 450
4.000% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4%			4%	4%	4%
Proceeds from issuance of unsecured debt	$ 500
4.375% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)				4.375%	4.375%	4.375%	4.375%
Principal amount of debt							$ 400

DEBT - Receivables Facility (De

DEBT - Receivables Facility (Details) $ in Millions	4 Months Ended
DEBT - Receivables Facility (Details) $ in Millions	Jun. 16, 2023 USD ($)	Apr. 01, 2023 USD ($)	Apr. 07, 2017 USD ($) customer
Master Repurchase And Framework Agreements, The Amendments
Debt Instrument [Line Items]
Number of customers \| customer			3
Financing receivable, before allowance for credit loss			$ 400
Line of credit facility, maximum amount outstanding during period	$ 160
Receivables Facility
Debt Instrument [Line Items]
Receivables facility borrowings		$ 380
Receivables facility \| Asset Pledged as Collateral
Debt Instrument [Line Items]
Financing receivable pledged as collateral		$ 422.2

DEBT - Interest Rate Swap Agree

DEBT - Interest Rate Swap Agreements (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Instrument 1
Derivative [Line Items]
Derivative, notional amount	$ 200
Fixed Rate	0.49%
Instrument 2
Derivative [Line Items]
Derivative, notional amount	$ 200
Fixed Rate	0.80%
Instrument 3
Derivative [Line Items]
Derivative, notional amount	$ 150
Fixed Rate	3.37%
Instrument 4
Derivative [Line Items]
Derivative, notional amount	$ 50
Fixed Rate	3.34%
Instrument 5
Derivative [Line Items]
Derivative, notional amount	$ 100
Fixed Rate	4.74%
Derivatives designated as hedging instruments \| Interest Rate Swap
Derivative [Line Items]
Derivative, notional amount	$ 700	$ 600	$ 800

DEBT - Weighted Average Interes

DEBT - Weighted Average Interest Rate (Details)	Mar. 30, 2024	Apr. 01, 2023
Debt Disclosure [Abstract]
Weighted average interest rate (percentage)	5.90%	5.30%

EQUITY - Summary of the Changes

EQUITY - Summary of the Changes in Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended					6 Months Ended
	Mar. 30, 2024	Dec. 30, 2023	Sep. 30, 2023	Apr. 01, 2023	Jan. 01, 2022	Mar. 30, 2024	Apr. 01, 2023
Schedule of Equity Method Investments [Line Items]
Dividends declared (USD per share)		$ 0.66	$ 0.66	$ 0.66	$ 0.66
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total equity, beginning balance	$ (385.4)	$ (267.3)		$ 59.5		$ (267.3)	$ 147.7
Net income (loss)	157.5	(80.5)		109.4	$ (64.7)	77	44.7
Other comprehensive income (loss)	3	(8.9)		(17.8)	(24.6)	(5.9)	(42.4)
Other comprehensive income (loss)	3			(17.8)		(5.9)	(42.4)
Share-based compensation	12.4	11.7		37.2	20.8
Dividends declared	(38.1)	(38)		(37)	(37.5)
Treasury share purchases	(1.7)	(3.1)		(5.6)	(0.8)
Treasury share issuances	1.3	0.7		(8.1)	18.7
Total equity, ending balance	(250.9)	(385.4)	$ (267.3)	137.5		(250.9)	137.5
Common Shares and Capital in Excess of Stated Value
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	349.6	353.1		367.6		353.1	364
Share-based compensation	12.4	11.7		37.2	20.8
Treasury share issuances	(8.3)	(15.2)		(30.4)	(17.2)
Equity ending balance	353.7	349.6	353.1	374.3		353.7	374.3
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	372.4	490.9		917.9		490.9	1,020.1
Net income (loss)	157.5	(80.5)		109.4	(64.7)
Dividends declared	(38.1)	(38)		(37)	(37.5)
Equity ending balance	491.8	372.4	490.9	990.3		491.8	990.3
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	(985.7)	(998.5)		(1,056.7)		(998.5)	(1,091.8)
Treasury share purchases	(1.7)	(3.1)		(5.6)	(0.8)
Treasury share issuances	9.6	15.9		22.3	35.9
Equity ending balance	(977.8)	(985.7)	(998.5)	(1,040)		(977.8)	(1,040)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	(121.7)	(112.8)		(169.3)		(112.8)	(144.6)
Other comprehensive income (loss)	3	(8.9)		(17.8)	$ (24.6)
Equity ending balance	$ (118.6)	$ (121.7)	$ (112.8)	$ (187.1)		$ (118.6)	$ (187.1)

EQUITY - Accumulated Other Comp

EQUITY - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ 5	$ (12.6)	$ (3.8)	$ (38.7)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.4	(11.4)	(3.7)	(20.3)
Income tax benefit (expense)	(2.4)	6.2	1.6	16.6
Total other comprehensive income (loss)	3	(17.8)	(5.9)	(42.4)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(121.7)	(169.3)	(112.8)	(144.6)
Equity ending balance	(118.6)	(187.1)	(118.6)	(187.1)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(18.8)	(21.7)	(21.9)	(28.9)
Other comprehensive income (loss) before reclassifications	(2.6)	1.1	0.5	8.3
Amounts reclassified from accumulated other comprehensive net income (loss)	0	0	0	0
Income tax benefit (expense)	0	0	0	0
Total other comprehensive income (loss)	(2.6)	1.1	0.5	8.3
Equity ending balance	(21.4)	(20.7)	(21.4)	(20.7)
Net Unrealized Gain (Loss) On Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	10.4	24.8	20.1	33.3
Other comprehensive income (loss) before reclassifications	8.2	(6.4)	(2.8)	(12.9)
Amounts reclassified from accumulated other comprehensive net income (loss)	(1.2)	(11)	(3.2)	(16)
Income tax benefit (expense)	(1.8)	4.4	1.5	7.4
Total other comprehensive income (loss)	5.2	(13)	(4.5)	(21.5)
Equity ending balance	15.7	11.8	15.7	11.8
Net Unrealized Gain (Loss) On Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(39.5)	(100.2)	(38.6)	(79.7)
Other comprehensive income (loss) before reclassifications	(0.6)	(7.3)	(1.5)	(34.1)
Amounts reclassified from accumulated other comprehensive net income (loss)	0	0	0	0
Income tax benefit (expense)	0	1.7	0	8.1
Total other comprehensive income (loss)	(0.6)	(5.6)	(1.5)	(26)
Equity ending balance	(40.1)	(105.7)	(40.1)	(105.7)
Pension and Other Post-Retirement Benefit Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(73.8)	(72.2)	(72.4)	(69.3)
Other comprehensive income (loss) before reclassifications	0	0	0	0
Amounts reclassified from accumulated other comprehensive net income (loss)	1.6	(0.4)	(0.5)	(4.3)
Income tax benefit (expense)	(0.6)	0.1	0.1	1.1
Total other comprehensive income (loss)	1	(0.3)	(0.4)	(3.2)
Equity ending balance	$ (72.9)	$ (72.6)	$ (72.9)	$ (72.6)

EQUITY - Dividends (Details)

EQUITY - Dividends (Details) - $ / shares	3 Months Ended
EQUITY - Dividends (Details) - $ / shares	Dec. 30, 2023	Sep. 30, 2023	Apr. 01, 2023	Jan. 01, 2022
Equity [Abstract]
Dividends declared (USD per share)	$ 0.66	$ 0.66	$ 0.66	$ 0.66

EQUITY - Total Share-based Comp

EQUITY - Total Share-based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Equity [Abstract]
Share-based compensation	$ 28.1	$ 37.2	$ 44.1	$ 57.9
Related tax benefit recognized	$ 4.6	$ 6.1	$ 7.2	$ 10.8

EQUITY - Performance Share-base

EQUITY - Performance Share-based Award Activity (Details) - Performance-based awards - $ / shares	6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
No. of Units
Awards outstanding at beginning of period (shares)	544,790
Granted (shares)	232,801
Vested (shares)	(181,791)
Forfeited (shares)	(185,740)
Awards outstanding at end of period (shares)	410,060
Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at beginning of period (USD per share)	$ 76.85
Granted (USD per share)	74.95	$ 65.97
Vested (USD per share)	59.88
Forfeited (USD per share)	64.66
Awards outstanding at end of period (USD per share)	$ 87.03
Vested average percentage of target performance of shares granted	100%

EQUITY - Performance-Based Awar

EQUITY - Performance-Based Awards, Additional Information (Details) - Performance-based awards - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Mar. 30, 2024	Mar. 30, 2024	Apr. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)		$ 74.95	$ 65.97
Cost not yet recognized	$ 8.6	$ 8.6
Cost not yet recognized, period (years)		2 years 7 months 6 days
Units vested, value		$ 10.6	$ 17.5
Compensation cost related to nonvested stock options	12	12
Deferred Compensation Liability, Current	$ 8.2	$ 8.2
Award vesting period	3 years
Vested average percentage of target performance of shares granted		100%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested average percentage of target performance of shares granted	0%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested average percentage of target performance of shares granted	325%

EQUITY - Performance Share Assu

EQUITY - Performance Share Assumptions (Details) - Performance-based awards	6 Months Ended
	Mar. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected market price volatility (percent)	36.60%
Risk-free interest rate (percent)	4.50%

EARNINGS PER COMMON SHARE - Cal

EARNINGS PER COMMON SHARE - Calculation of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income	$ 157.5	$ 109.4	$ 77	$ 44.7
Basic net loss per common share:
Weighted-average common shares outstanding during the period (in shares)	56,800,000	56,000,000	56,700,000	55,800,000
Income (loss) from continuing operations (USD per share)	$ 2.77	$ 1.95	$ 1.36	$ 0.80
Diluted net income per common share
Weighted-average common shares outstanding during the period (in shares)	56,800,000	56,000,000	56,700,000	55,800,000
Dilutive potential Common Shares (in shares)	600,000	500,000	600,000	300,000
Weighted-average common shares outstanding during the period plus dilutive potential common shares (in shares)	57,400,000	56,500,000	57,300,000	56,100,000
Diluted income (loss) per common share (USD per share)	$ 2.74	$ 1.94	$ 1.34	$ 0.80
Options
Diluted net income per common share
Number of anti-dilutive potential common shares excluded from the calculation (in shares)	400,000	200,000	600,000	300,000

EARNINGS PER COMMON SHARE - Add

EARNINGS PER COMMON SHARE - Additional Information (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Earnings Per Share [Abstract]
Weighted-average common shares outstanding during the period plus dilutive potential common shares (in shares)	57.4	56.5	57.3	56.1

INCOME TAXES (Details)

INCOME TAXES (Details)	6 Months Ended
INCOME TAXES (Details)	Mar. 30, 2024	Apr. 01, 2023
Income Tax Examination [Line Items]
Effective tax rate related to continuing operations	27.10%	19.50%

CONTINGENCIES (Details)

CONTINGENCIES (Details) $ in Millions	Mar. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrual for environmental actions	$ (2.9)

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Not Designated as Hedging Instrument \| Currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 114.2	$ 123.1	$ 119.1
Designated as Hedging Instruments \| Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	700	$ 600	$ 800
(Gain) loss related to interest rate swap agreements expected to be reclassified	(9.7)
Designated as Hedging Instruments \| Commodity hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) related to commodity hedges expected to be reclassified	$ 0.2

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Commodity Contracts (Details)	6 Months Ended		12 Months Ended
	Mar. 30, 2024 T gal	Apr. 01, 2023 T gal	Sep. 30, 2023 T gal
Urea (in tons)
Derivative [Line Items]
Outstanding commodity contracts, mass \| T	0	19,500	52,500
Diesel (in gallons)
Derivative [Line Items]
Outstanding commodity contracts, volume	1,428,000	2,394,000	1,974,000
Heating Oil (in gallons)
Derivative [Line Items]
Outstanding commodity contracts, volume	756,000	1,260,000	966,000

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Values of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives	$ 22.5	$ 40.2	$ 21.1
Designated as Hedging Instruments \| Interest rate swap agreements \| Other assets
Derivatives, Fair Value [Line Items]
Derivative asset	9.3	14.7	11.5
Designated as Hedging Instruments \| Interest rate swap agreements \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	13.6	16.7	12.7
Designated as Hedging Instruments \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives	22.1	33.7	23.8
Designated as Hedging Instruments \| Fair value, inputs, level 2 \| Interest rate swap agreements \| Other liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	(0.8)	0	0
Designated as Hedging Instruments \| Fair value, inputs, level 2 \| Commodity hedging instruments \| Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	0	0	(0.4)
Designated as Hedging Instruments \| Fair value, inputs, level 2 \| Commodity hedging instruments \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0	2.3	0
Not Designated as Hedging Instrument \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives	0.4	6.5	(2.7)
Not Designated as Hedging Instrument \| Fair value, inputs, level 2 \| Currency forward contracts \| Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	0	0	(2.3)
Not Designated as Hedging Instrument \| Fair value, inputs, level 2 \| Currency forward contracts \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.4	5.6	0
Not Designated as Hedging Instrument \| Fair value, inputs, level 2 \| Commodity hedging instruments \| Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	0	0	(0.4)
Not Designated as Hedging Instrument \| Fair value, inputs, level 2 \| Commodity hedging instruments \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	$ 0	$ 0.9	$ 0

DERIVATIVE INSTRUMENTS AND HE_6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on AOCI and Statements of Operations (Details) - Fair value, inputs, level 2 - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in Earnings	$ 1.2	$ (5.9)	$ (4.9)	$ (15.7)
Not Designated as Hedging Instrument \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in Earnings	$ (0.1)	$ (0.6)	$ (1.4)	$ 0.9
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales	Cost of sales	Cost of sales
Not Designated as Hedging Instrument \| Currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in Earnings	$ 1.3	$ (5.3)	$ (3.5)	$ (16.6)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in AOCL	$ 6.1	$ (4.8)	$ (2.1)	$ (9.6)
Amount of Gain / (Loss) Reclassified From AOCI Into Earnings	0.9	8.2	2.4	11.9
Cash Flow Hedging \| Interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in AOCL	5.8	(1.2)	(0.6)	(0.7)
Amount of Gain / (Loss) Reclassified From AOCI Into Earnings	$ 4.1	$ 3.7	$ 6.7	$ 5.1
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest expense	Interest expense	Interest expense	Interest expense
Cash Flow Hedging \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain / (Loss) Recognized in AOCL	$ 0.3	$ (3.6)	$ (1.5)	$ (8.9)
Amount of Gain / (Loss) Reclassified From AOCI Into Earnings	$ (3.2)	$ 4.5	$ (4.3)	$ 6.8
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales	Cost of sales	Cost of sales

FAIR VALUE MEASUREMENTS - Summa

FAIR VALUE MEASUREMENTS - Summary of Fair Value of Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Senior notes \| 4.000% Senior Notes
Liabilities
Interest rate of debt (percentage)	4%	4%	4%		4%
Senior notes \| 4.375% Senior Notes
Liabilities
Interest rate of debt (percentage)	4.375%	4.375%	4.375%	4.375%
Senior notes \| 4.500% Senior Notes
Liabilities
Interest rate of debt (percentage)	4.50%	4.50%	4.50%			4.50%
Senior notes \| 5.250% Senior Notes
Liabilities
Interest rate of debt (percentage)	5.25%	5.25%	5.25%				5.25%
Carrying Amount \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring
Assets
Cash equivalents	$ 28.1	$ 1.2	$ 2.9
Carrying Amount \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring \| Investment securities in non-qualified retirement plan assets
Assets
Other	42.3	36.3	39
Carrying Amount \| Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Assets
Other	84.5	85.8	84.8
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Revolving loans
Liabilities
Debt instruments	314.2	88.3	642.5
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Term loans
Liabilities
Debt instruments	900	925	950
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.000% Senior Notes
Liabilities
Debt instruments	500	500	500
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.375% Senior Notes
Liabilities
Debt instruments	400	400	400
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.500% Senior Notes
Liabilities
Debt instruments	450	450	450
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 5.250% Senior Notes
Liabilities
Debt instruments	250	250	250
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Receivables facility
Liabilities
Debt instruments	0	0	380
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Other debt
Liabilities
Debt instruments	5.5	0.4	3.1
Estimated Fair Value \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring
Assets
Cash equivalents	28.1	1.2	2.9
Estimated Fair Value \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring \| Investment securities in non-qualified retirement plan assets
Assets
Other	42.3	36.3	39
Estimated Fair Value \| Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Assets
Other	84.5	85.8	84.8
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Revolving loans
Liabilities
Debt instruments	314.2	88.3	642.5
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Term loans
Liabilities
Debt instruments	900	925	950
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.000% Senior Notes
Liabilities
Debt instruments	427.5	380	398.8
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.375% Senior Notes
Liabilities
Debt instruments	344	304	320.5
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.500% Senior Notes
Liabilities
Debt instruments	405	366.8	388.1
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 5.250% Senior Notes
Liabilities
Debt instruments	245.6	233.1	238.8
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Receivables facility
Liabilities
Debt instruments	0	0	380
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Other debt
Liabilities
Debt instruments	$ 5.5	$ 0.4	$ 3.1

FAIR VALUE MEASUREMENTS - Rollf

FAIR VALUE MEASUREMENTS - Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized losses included in OCI	$ 5	$ (12.6)	$ (3.8)	$ (38.7)
Net Unrealized Gain (Loss) On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized losses included in OCI	(0.6)	(7.3)	(1.5)	(34.1)
Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized gains included in net earnings	0.1	0.9	0.2	1.9
Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments \| Net Unrealized Gain (Loss) On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized losses included in OCI	(0.6)	(7.3)	(1.5)	(34.1)
Fair value, inputs, level 3 \| Estimated Fair Value \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of period	85	91.2	85.8	117
Fair value at end of period	$ 84.5	$ 84.8	$ 84.5	$ 84.8

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details) - Convertible debt investments - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized cost basis of investment	$ 226	$ 224	$ 225.8
Unrealized gain (loss) on investment	(141.4)	(139.2)	(140)
Debt Securities, Available-for-Sale, Allowance for Credit Loss	$ 101.3	$ 0	$ 101.3
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt term	3 years 4 months 24 days
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt term	5 years 6 months

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Lessee, Lease, Description [Line Items]
Expected lease liability	$ 299.6	$ 296.5	$ 280.6
Residual value of leased asset	5.2
Not Yet Commenced
Lessee, Lease, Description [Line Items]
Expected lease liability	$ 23.3

LEASES - Supplemental Balance S

LEASES - Supplemental Balance Sheet Information Schedule (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Leases [Abstract]
Operating lease right-of-use-assets	$ 273.1	$ 262.6	$ 255.9
Operating lease current lease liabilities	75.9	76.4	77.4
Operating lease non-current lease liabilities	223.7	220.1	203.2
Total operating lease liabilities	299.6	296.5	280.6
Finance lease right-of-use assets	15	14.5	15.7
Finance lease current lease liabilities	2.3	1.9	1.9
Finance lease non-current lease liabilities	15.2	15	16
Total finance lease liabilities	$ 17.5	$ 16.9	$ 17.9

LEASES - Components of Lease Co

LEASES - Components of Lease Cost Schedule (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Leases [Abstract]
Operating lease cost	$ 20.3	$ 23.9	$ 42.3	$ 46.1
Variable lease cost	9.2	7.1	15.8	13.6
Amortization of right-of-use assets	0.6	0.6	1.2	2
Interest on lease liabilities	0.2	0.1	0.4	0.4
Total finance lease cost	0.8	0.7	1.6	2.4
Operating lease amortization of ROU assets	$ 16.5	$ 23.8	$ 34.7	$ 42.8

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information and Non-Cash Activity Schedule (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Lease, Cost [Abstract]
Operating cash flows from operating leases, net	$ 49.3	$ 46.3
Operating cash flows from finance leases	0.4	0.4
Financing cash flows from finance leases	1	1.8
Right-of-use assets obtained in exchange for lease obligations, operating leases	41.6	32.5
Right-of-use assets obtained in exchange for lease obligations, finance leases	$ 1.7	$ 0

LEASES - Weighted-Average Remai

LEASES - Weighted-Average Remaining Lease Term and Discount Rate Schedule (Details)	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Leases [Abstract]
Operating leases, weighted average remaining term (in years)	5 years 4 months 24 days	5 years 4 months 24 days	4 years 9 months 18 days
Finance leases, weighted average remaining term (in years)	8 years 8 months 12 days	9 years 6 months	9 years 9 months 18 days
Operating leases, weighted average discount rate (percent)	5.60%	5.20%	4%
Finance leases, weighted average discount rate (percent)	4.60%	4.40%	4.40%

LEASES - Maturities of Lease Li

LEASES - Maturities of Lease Liabilities by Fiscal Year Schedule (Details) - USD ($) $ in Millions	Mar. 30, 2024	Sep. 30, 2023	Apr. 01, 2023
Operating Leases
2024 (remainder of the year)	$ 47.8
2025	82.8
2026	64.8
2027	40.8
2028	31.2
Thereafter	82.1
Total lease payments	349.5
Less: Imputed interest	(49.9)
Total lease liabilities	299.6	$ 296.5	$ 280.6
Finance Leases
2024 (remainder of the year)	1.5
2025	3
2026	2.6
2027	2.2
2028	1.9
Thereafter	10.2
Total lease payments	21.4
Less: Imputed interest	(3.9)
Total lease liabilities	$ 17.5	$ 16.9	$ 17.9

SEGMENT INFORMATION - Net Sales

SEGMENT INFORMATION - Net Sales, Profit (Loss), and Assets by Segment (Details) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Mar. 30, 2024 USD ($) segment	Apr. 01, 2023 USD ($)
Segment Reporting [Abstract]
Number of reportable segments \| segment			3
Segment Reporting Information [Line Items]
Net sales	$ 1,525.4	$ 1,531.5	$ 1,935.8	$ 2,058.1
Impairment, restructuring and other	(2.1)	(21.8)	5	(30.2)
Equity in loss of unconsolidated affiliates	(7)	(7.3)	(29.5)	(18.7)
Interest expense	(44.1)	(48.3)	(86.8)	(91)
Other non-operating income (expense), net	(1.2)	(0.8)	(2.9)	0.8
Continuing Operations
Segment Reporting Information [Line Items]
Income before income taxes	219.8	149.8	105.6	55.5
Intangible asset amortization	(3.9)	(6.4)	(7.9)	(14.1)
Impairment, restructuring and other	(77)	(140.5)	(64.1)	(159.2)
Equity in loss of unconsolidated affiliates	(7)	(7.3)	(29.5)	(18.7)
Interest expense	(44.1)	(48.3)	(86.8)	(91)
Other non-operating income (expense), net	(1.2)	(0.8)	(2.9)	0.8
Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income before income taxes	388.7	395.2	358.5	411.7
Continuing Operations \| Corporate
Segment Reporting Information [Line Items]
Income before income taxes	(35.7)	(42.1)	(61.7)	(74)
U.S. Consumer
Segment Reporting Information [Line Items]
Net sales	1,379.8	1,357.4	1,686.5	1,726.3
U.S. Consumer \| Growing media and mulch
Segment Reporting Information [Line Items]
Net sales	591.5	517.2	663.5	614.3
U.S. Consumer \| Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income before income taxes	385.7	397.4	370.3	428.7
Hawthorne
Segment Reporting Information [Line Items]
Net sales	66.4	92.7	146.6	224.2
Hawthorne \| Growing environments
Segment Reporting Information [Line Items]
Net sales	6.3	16	17.8	41.5
Hawthorne \| Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income before income taxes	(3.4)	(16.8)	(13)	(33)
Other
Segment Reporting Information [Line Items]
Net sales	79.2	81.4	102.7	107.6
Other \| Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income before income taxes	$ 6.4	$ 14.6	$ 1.2	$ 16

SEGMENT INFORMATION - Net Sal_2

SEGMENT INFORMATION - Net Sales by Product Category (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Revenue from External Customer [Line Items]
Net sales	$ 1,525.4	$ 1,531.5	$ 1,935.8	$ 2,058.1
U.S. Consumer
Revenue from External Customer [Line Items]
Net sales	1,379.8	1,357.4	1,686.5	1,726.3
U.S. Consumer \| Lawn care
Revenue from External Customer [Line Items]
Net sales	509.8	534.3	628.6	679.7
U.S. Consumer \| Growing media and mulch
Revenue from External Customer [Line Items]
Net sales	591.5	517.2	663.5	614.3
U.S. Consumer \| Controls
Revenue from External Customer [Line Items]
Net sales	137.1	134.6	190.5	192.8
U.S. Consumer \| Roundup® marketing agreement
Revenue from External Customer [Line Items]
Net sales	64.6	70.7	88	91
U.S. Consumer \| Other, primarily gardening
Revenue from External Customer [Line Items]
Net sales	76.8	100.6	115.9	148.5
Hawthorne
Revenue from External Customer [Line Items]
Net sales	66.4	92.7	146.6	224.2
Hawthorne \| Lighting
Revenue from External Customer [Line Items]
Net sales	16.1	18.1	48	68.4
Hawthorne \| Nutrients
Revenue from External Customer [Line Items]
Net sales	24.6	24.4	41.2	47.2
Hawthorne \| Growing environments
Revenue from External Customer [Line Items]
Net sales	6.3	16	17.8	41.5
Hawthorne \| Growing media
Revenue from External Customer [Line Items]
Net sales	10.2	18.5	21.4	36.3
Hawthorne \| Other, primarily hardware
Revenue from External Customer [Line Items]
Net sales	9.2	15.7	18.2	30.8
Other
Revenue from External Customer [Line Items]
Net sales	79.2	81.4	102.7	107.6
Other \| Lawn care
Revenue from External Customer [Line Items]
Net sales	31.5	29.7	33.8	32.3
Other \| Growing media
Revenue from External Customer [Line Items]
Net sales	23.3	24.9	36.5	40.3
Other \| Other, primarily gardening and controls
Revenue from External Customer [Line Items]
Net sales	$ 24.4	$ 26.8	$ 32.4	$ 35

SEGMENT INFORMATION - Net Sal_3

SEGMENT INFORMATION - Net Sales by Geographic Area (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024	Apr. 01, 2023
Segment Reporting Information [Line Items]
Net sales	$ 1,525.4	$ 1,531.5	$ 1,935.8	$ 2,058.1
United States
Segment Reporting Information [Line Items]
Net sales	1,441.7	1,447.2	1,807.5	1,912.2
International
Segment Reporting Information [Line Items]
Net sales	$ 83.7	$ 84.3	$ 128.3	$ 145.9